Projects per year
Personal profile
Research interests
Dr. David Boulware is an infectious disease physician-scientist with formal training in public health, clinical trials, and tropical medicine. As a translational researcher, Dr. Boulware combines his clinical research training with basic science investigations into disease pathogenesis. His primary research interests are in meningitis including diagnosis, prevention, and treatment. The overall objective is to translate knowledge into improved care and updated US and international guidelines.
Dr. Boulware leads a Platform Trial on cryptococcal meningitis (PLATFORM-CM) investigating new antifungal therapies with the objective to bring new antifungal therapies forward to FDA approval, thereby making these new antifungal therapies available for Americans. Cryptococcal meningitis, a fungal infection in and around the brain, is the most common cause of meningitis in Africa. This also occurs in the US with an estimated incidence of 1.1 per 100,000 Americans. While progress has been made, the mortality through 4-months remains ~30% with current first-line therapy.
A second focus is on clinical research for TB meningitis, which is the second most common cause of meningitis in Africa. His team has worked on diagnostics for TB meningitis, changing first-line recommended diagnostics. Still more work needs to be done to improve diagnosis. His collaborative team also conducts clinical trials for TB meningitis, investigating new therapies to improve upon the ~45% mortality rate.
Dr. Boulware has active research collaborations in Uganda, South Africa, Ethiopia, Indonesia, Brazil, United Kingdom, and The Netherlands, leading a multidisciplinary, international research team which is highly collaborative in working with others.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 1 No Poverty
-
SDG 2 Zero Hunger
-
SDG 3 Good Health and Well-being
-
SDG 4 Quality Education
-
SDG 5 Gender Equality
-
SDG 6 Clean Water and Sanitation
-
SDG 8 Decent Work and Economic Growth
-
SDG 9 Industry, Innovation, and Infrastructure
-
SDG 10 Reduced Inequalities
-
SDG 12 Responsible Consumption and Production
-
SDG 16 Peace, Justice and Strong Institutions
-
SDG 17 Partnerships for the Goals
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Infectious Disease Training in Clinical Investigation
Boulware, D. R. (PI)
NIH NATIONAL INST OF ALLERGY & INFECT DI
8/21/26 → 7/31/31
Project: Research project
-
STeroids and enhanced Antibiotics for the treatment of Refractory Sepsis (STARS)
Boulware, D. R. (PI)
UNIVERSITY OF VIRGINIA, NIH NATIONAL INST OF ALLERGY & INFECT DI
9/20/25 → 8/31/30
Project: Research project
-
Understanding the causes of second episode cryptococcal meningitis to improve diagnosis and treatment
Bahr, N. (PI), Dai, B. (PI), Nicol, M. R. (PI), Selmecki, A. M. (PI), Boulware, D. R. (CoI) & Rajasingham, R. (CoI)
NIH NAT INST OF NEURO DISORDERS & STROKE
9/10/25 → 8/31/29
Project: Research project
-
Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (HISTO-FACT)
Bahr, N. (PI), Dai, B. (PI), Nicol, M. R. (PI), Boulware, D. R. (CoI), Lofgren, S. M. (Other Role) & Pullen, M. F. (Other Role)
NIH NATIONAL INST OF ALLERGY & INFECT DI
9/3/25 → 8/31/32
Project: Research project
-
Midcareer Mentoring for Clinical Research in HIV/AIDS-related cryptococcal and TB meningitis
Boulware, D. R. (PI) & Rhein, J. R. (Other Role)
NIH NATIONAL INST OF ALLERGY & INFECT DI
8/20/24 → 7/31/29
Project: Research project
-
Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis
Boulware, D. R., Meya, D. B., Muzoora, C., Rolfes, M. A., Hullsiek, K. H., Musubire, A., Taseera, K., Nabeta, H. W., Schutz, C., Williams, D. A., Rajasingham, R., Rhein, J., Thienemann, F., Lo, M. W., Nielsen, K., Bergemann, T. L., Kambugu, A., Manabe, Y. C., Janoff, E. N. & Bohjanen, P. R. & 1 others, , 2014, In: New England Journal of Medicine. 370, 26, p. 2487-2498 12 p.Research output: Contribution to journal › Article › peer-review
Open Access456 Link opens in a new tab Scopus citations -
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
Ambition Study Group, Mar 24 2022, In: New England Journal of Medicine. 386, 12, p. 1109-1120 12 p.Research output: Contribution to journal › Article › peer-review
Open Access273 Link opens in a new tab Scopus citations -
Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis
Meya, D. B., Cresswell, F. V., Dai, B., Engen, N., Naidoo, K., Ganiem, A. R., Imran, D., Kabahubya, M., Lessells, R. J., Yunivita, V., Estiasari, R., Tugume, L., Hlabisa, B., Kurniawati, M. Y., Sagita, N., Kagimu, E., Maharani, K., Gakuru, J., Gaharu, M. N. & Mugabi, T. & 15 others, , Dec 18 2025, In: New England Journal of Medicine. 393, 24, p. 2434-2446 13 p.Research output: Contribution to journal › Article › peer-review
Open Access20 Link opens in a new tab Scopus citations -
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Boulware, D. R., Pullen, M. F., Bangdiwala, A. S., Pastick, K., Lofgren, S. M., Okafor, E., Skipper, C. P., Nascene, A., Nicol, M. R., Abassi, M., Engen, N. S., Cheng, M. P., Lother, S. A., MacKenzie, L. J., Drobot, G., Marten, N., Zarychanski, R., Kelly, L. E., Schwartz, I. S. & McDonald, E. G. & 3 others, , Aug 6 2020, In: New England Journal of Medicine. 383, 6, p. 517-525 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1053 Link opens in a new tab Scopus citations -
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
COVID-OUT Trial Team, Aug 18 2022, In: The New England journal of medicine. 387, 7, p. 599-610 12 p.Research output: Contribution to journal › Article › peer-review
Open Access212 Link opens in a new tab Scopus citations
Datasets
-
COAT Trial Public Dataset
Boulware, D. R., investigator, Jul 1 2015
https://www.researchgate.net/publication/280156939_COAT_Trial_Public_Dataset_03December2013
Dataset
-
Meningitis Studies Datasets
Boulware, D. R., Harvard Dataverse, Jan 1 2025
https://dataverse.harvard.edu/dataverse/meningitis-studies
Dataset
-
Data for "Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort Study"
Gakuru, J., Boulware, D., Dai, B. & Williams, D. A., Harvard Dataverse, May 19 2025
DOI: 10.7910/dvn/ggcsjy, https://dataverse.harvard.edu/citation?persistentId=doi:10.7910/DVN/GGCSJY
Dataset
-
The effect of sertraline on depression and associations with persistent depression in survivors of HIV-related cryptococcal meningitis
Lofgren, S. & Boulware, D. R., ZENODO, 2021
DOI: 10.5061/dryad.n5tb2rbtr, https://zenodo.org/record/4437343 and one more link, http://datadryad.org/stash/dataset/doi:10.5061/dryad.n5tb2rbtr (show fewer)
Dataset
Press/Media
-
The Strange and Twisted Tale of Hydroxychloroquine
11/11/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
Trump pushes FDA to quickly clear coronavirus antibody treatments, erroneously calling them a "cure"
10/9/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
Trump’s age, health woes raise his risk for COVID-19 illness
10/2/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
Hydroxychloroquine didn't prevent Covid-19 among health care workers in new study
9/30/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
Twitter deletes video promoted by Trump on hydroxychloroquine use for coronavirus
7/28/20
1 item of Media coverage
Press/Media: Expert Comment or Interview